Skip to main content
. 2023 Oct 10;16(11):2382–2393. doi: 10.1111/cts.13639

TABLE 5.

Stepwise linear regression results for eGFR at 60 months post‐transplant (N = 106).

Variable % With characteristic if categorical/Median [interquartile range] if continuous Univariable p value Multivariable p value Model a Coeff ± SE
Group A 33.0% (35/106) 0.46
Group B 30.2% (32/106) 0.13
Group C 36.8% (39/106) 0.03 (√) 0.01 −9.360 ± 3.553
Recipient age (years) 48.3 [34.6–58.6] 0.10
Male recipient 67.9% (72/106) 0.41
African–American recipient 17.0% (18/106) 0.03
Hispanic recipient 38.7% (41/106) 0.45
Recipient BMI 25.2 [22.4–28.1] 0.80
Pretransplant CVD 17.0% (18/106) 0.47
Pretransplant diabetes 12.3% (13/106) 0.64
DD recipient 81.1% (86/106) 0.64
Nonstandard DD recipient 13.2% (14/106) 0.08
Donor age (years) 36.5 [23.0–47.0] 0.000001 (√) <0.000001 −0.770 ± 0.126
# HLA mismatches 3.5 [3.0–4.0] 0.31
First BPAR ≤60 months 16.0% (17/106) 0.001 (√) 0.00008 −19.212 ± 4.672
NODAT ≤60 months 26.4% (28/106) 0.41
Rank {Avg CNI level: 0–60 months} 0.51 [0.26–0.76] 0.76
Multivariable linear regression model for eGFR at 60 mo post‐transplant (N = 106), considering the effect of rank {avg CNI level during 0–60 months}
Variable Multivariable p value Model b Coeff ± SE
Group C 0.01 −9.373 ± 3.573
Donor age (years) <0.000001 −0.770 ± 0.126
First BPAR ≤60 months 0.0001 −19.135 ± 4.776
Rank {Avg CNI level: 0–60 months} 0.93 0.528 ± 6.050

Note: (√) Represents selection into the multivariable linear regression model.

Abbreviations: Avg, average; BMI, body mass index; BPAR, biopsy‐proven acute rejection; CNI, calcineurin inhibitor; Coeff, coefficient; CVD, cardiovascular disease; DD, deceased donor; eGFR, estimated glomerular filtration rate; HLA, human leukocyte antigen; NODAT, new onset diabetes after transplant.

a

The 3 variables selected into the multivariable model were defined as follows: group C = {1 if recipient was randomized into group C, 0 otherwise}; donor age (years) (continuous variable); and first BPAR ≤60 months = {1 if the patient experienced a first BPAR during the first 60 months post‐transplant, 0 otherwise}. The estimated intercept term ± SE for the multivariable model was: 91.508 ± 5.108, and the coefficient of multiple determination was 0.37.

b

The 4 variables included in this multivariable model were defined as follows: group C = {1 if recipient was randomized into group C, 0 otherwise}; donor age (years) (continuous variable); first BPAR ≤60 months ={1 if the patient experienced a first BPAR during the first 60 months post‐transplant, 0 otherwise}; and rank {Avg CNI level: 0–60 months} = rank of the average CNI trough level during 0–60 months post‐transplant. The estimated intercept term ± SE for the multivariable model was: 91.254 ± 5.898, and the coefficient of multiple determination was 0.37.